About us
The UK Liver Alliance was set up to provide a single united voice for the liver community. The Alliance is a coalition of more than 30 organisations who are committed to improving liver health for all patients.
We have a bold vision to bring together the liver disease community to strengthen prevention, improve earlier diagnosis and reduce stark health inequalities in liver disease outcomes and care across the UK – including the sharp rise in avoidable deaths in our most disadvantaged communities.
The Alliance builds on the Lancet Commission on Liver Health. We aim to strengthen the UK’s approach to prevention, diagnosis, and treatment of liver disease – protecting the next generation from avoidable disease and premature death.
Our members
The UK Liver Alliance plays a pivotal role in driving policy change to improve outcomes for patients. The Alliance’s objectives are to:
- Influence national policy.
- Improve quality and standards of care.
- Generate and evaluate data on the burden of liver disease in the UK to provide a robust evidence base.
- Secure an appropriate workforce to provide care for people with liver disease.
- Remove inequalities and unwarranted variations in care across UK Nations and regions.
Our Chairs
Pamela Healy OBE
Chair of the UK Liver Alliance and Chief Executive of the British Liver Trust
Professor Philip Newsome PhD, FRCPE
Vice Chair of the UK Liver Alliance and Director for the Roger Williams Institute of Hepatology
Bringing together patients, charities, medical royal colleges, NHS organisations and government representatives – the UK Liver Alliance provides a single voice of advocacy on liver health in the UK.
If your organisation would like to join the Alliance please email ukla@britishlivertrust.org.uk.